{"id":61504,"date":"2025-06-30T10:03:47","date_gmt":"2025-06-30T08:03:47","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/"},"modified":"2025-06-30T10:03:47","modified_gmt":"2025-06-30T08:03:47","slug":"endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/","title":{"rendered":"Endo Tools Therapeutics and Fujifilm Middle East FZE Partner to Extend Access to Innovative Treatments for Obesity"},"content":{"rendered":"
\n

\nPartnership enables Fujifilm Middle East FZE to distribute Endo Tools Therapeutics\u2019 groundbreaking endomina\u00ae product range across 18 countries in Middle East and Africa (MEA)<\/b><\/p>\n

<\/a>
<\/a><\/p>\n

\nEndo Tools Therapeutics\u2019 minimally invasive platform provides novel endoscopic gastroplasty procedure for adults with obesity, a disease increasing in prevalence in MEA region<\/b><\/p>\n

GOSSELIES, Belgium & DUBAI, United Arab Emirates–(BUSINESS WIRE)–Endo Tools Therapeutics (ETT),<\/b> a company developing and marketing advanced endoscopic medical devices, and Fujifilm Middle East FZE, a subsidiary of FUJIFILM Holdings Corporation, today announce their strategic partnership, to enable patients living with obesity in the Middle East and Africa to access a novel endoscopic treatment through ETT\u2019s endomina\u00ae platform.<\/p>\n

\nThe platform enables endoscopists to perform a volume reduction of the stomach using a minimally invasive procedure performed via oral entry.<\/p>\n

\n“Endo Tool Therapeutics\u2019 partnership with Fujifilm is a key strategic step in our international expansion. Fujifilm\u2019s extensive network and deep knowledge of the region make it an ideal partner to bring the benefits of endomina to a broader patient population increasingly affected by obesity,” said Alexandre Chau, CEO of Endo Tools Therapeutics.<\/p>\n

\nIt was estimated that worldwide the number of people living with obesity had reached 890 million in 2022, a figure that has doubled over the last 30\u2009years. In the Middle East, the prevalence of obesity is 21.2%. Obesity contributes to increased risks of comorbidities such as diabetes, cardiovascular disease and certain cancers; high rates pose serious socio-economic and health system challenges in the region1<\/sup>.<\/p>\n

\n\u201cWe are excited to bring new, minimally invasive solutions like endomina into our portfolio. Offering innovative treatment options for patients living with obesity reflects our ongoing commitment to advancing patient care and outcomes across the region,\u201d said Atsushi Tateishi, General Manager of Fujifilm Middle East FZE. \u201cThrough this collaboration, we aim to make meaningful advances in obesity care and improve access to cutting-edge therapies for healthcare providers and patients alike.\u201d<\/p>\n

\nAbout Fujifilm Middle East FZE
\n
<\/b>Fujifilm Middle East & Africa, located in Dubai, is a subsidiary of FUJIFILM Holdings Corporation, Tokyo, Japan. Fujifilm was founded in 1934 as a producer of photographic film under the name Fuji Photo Film Co. Ltd. The company has built up a wealth of advanced technologies in the field of photo imaging, and in line with its efforts to become a comprehensive healthcare company, Fujifilm is now applying these technologies to the prevention, diagnosis and treatment of diseases in the medical and life science fields. Fujifilm MEA performs its operations in medical systems, graphic systems, device technology, electronic imaging, photo imaging, optical devices, recording media and industrial products in various offices throughout the Middle East & Africa.
\n
www.fujifilm.com\/ae\/en<\/a><\/p>\n

\nAbout Endo Tools Therapeutics
\n
<\/b>Located in Gosselies, Belgium, Endo Tools Therapeutics S.A. (ETT) offers a portfolio of advanced, incisionless and minimally invasive endoscopic medical devices. The company\u2019s mission is to develop solutions that expand the range of gastrointestinal procedures that can be performed using standard gastroscopes. By developing minimally invasive treatment solutions, ETT aims to reduce the number of complications, and the length of hospital stay for patients, and in doing so improve their comfort. The initial results from bariatric procedures performed using ETT\u2019s soft tissue approximation devices have been published in multiple scientific articles, e.g. GIE<\/i> in 2017<\/a>, Endoscopy<\/i> in 2018<\/a>, Gut<\/i> in 2020<\/a>, EIO<\/i> in 2022<\/a> and GIE<\/i> in 2024<\/a>. Moreover, endomina is included in the joint ASGE-ESGE guideline<\/i><\/a> <\/i>on primary endoscopic bariatric and metabolic therapies.
\n
To date, over 1,200 gastroplasty procedures have been performed using Endo Tools Therapeutics\u2019 devices across Europe, the US and the Middle East.
\n
In Europe the devices are approved for use in endoscopic gastroplasty procedures for the treatment of obesity, while in the US they are cleared for placement of sutures and approximation of soft tissue in the gastrointestinal tract.
\n
www.endotools.com<\/a><\/p>\n

Contacts<\/b> <\/p>\n

\nMedia and analyst contact
\n
Andrew Lloyd & Associates<\/b>
Celine Gonzalez<\/a> \u2013 Carol Leslie<\/a>
UK: +44 1273 952 481
\n
US: +1 203 724 5950<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Partnership enables Fujifilm Middle East FZE to distribute Endo Tools Therapeutics\u2019 groundbreaking endomina\u00ae product range across 18 countries in Middle East and Africa (MEA) Endo Tools Therapeutics\u2019 minimally invasive platform provides novel endoscopic gastroplasty procedure for adults with obesity, a disease increasing in prevalence in MEA region GOSSELIES, Belgium & DUBAI, United Arab Emirates–(BUSINESS WIRE)–Endo … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61504","6":"format-standard","7":"category-industry"},"yoast_head":"\nEndo Tools Therapeutics and Fujifilm Middle East FZE Partner to Extend Access to Innovative Treatments for Obesity - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Endo Tools Therapeutics and Fujifilm Middle East FZE Partner to Extend Access to Innovative Treatments for Obesity - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Partnership enables Fujifilm Middle East FZE to distribute Endo Tools Therapeutics\u2019 groundbreaking endomina\u00ae product range across 18 countries in Middle East and Africa (MEA) Endo Tools Therapeutics\u2019 minimally invasive platform provides novel endoscopic gastroplasty procedure for adults with obesity, a disease increasing in prevalence in MEA region GOSSELIES, Belgium & DUBAI, United Arab Emirates–(BUSINESS WIRE)–Endo ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-30T08:03:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250630084663\/en\/2505963\/22\/ETT_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Endo Tools Therapeutics and Fujifilm Middle East FZE Partner to Extend Access to Innovative Treatments for Obesity\",\"datePublished\":\"2025-06-30T08:03:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\\\/\"},\"wordCount\":658,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250630084663\\\/en\\\/2505963\\\/22\\\/ETT_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\\\/\",\"name\":\"Endo Tools Therapeutics and Fujifilm Middle East FZE Partner to Extend Access to Innovative Treatments for Obesity - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250630084663\\\/en\\\/2505963\\\/22\\\/ETT_logo.jpg\",\"datePublished\":\"2025-06-30T08:03:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250630084663\\\/en\\\/2505963\\\/22\\\/ETT_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250630084663\\\/en\\\/2505963\\\/22\\\/ETT_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Endo Tools Therapeutics and Fujifilm Middle East FZE Partner to Extend Access to Innovative Treatments for Obesity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Endo Tools Therapeutics and Fujifilm Middle East FZE Partner to Extend Access to Innovative Treatments for Obesity - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/","og_locale":"en_US","og_type":"article","og_title":"Endo Tools Therapeutics and Fujifilm Middle East FZE Partner to Extend Access to Innovative Treatments for Obesity - Pharma Trend","og_description":"Partnership enables Fujifilm Middle East FZE to distribute Endo Tools Therapeutics\u2019 groundbreaking endomina\u00ae product range across 18 countries in Middle East and Africa (MEA) Endo Tools Therapeutics\u2019 minimally invasive platform provides novel endoscopic gastroplasty procedure for adults with obesity, a disease increasing in prevalence in MEA region GOSSELIES, Belgium & DUBAI, United Arab Emirates–(BUSINESS WIRE)–Endo ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/","og_site_name":"Pharma Trend","article_published_time":"2025-06-30T08:03:47+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250630084663\/en\/2505963\/22\/ETT_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Endo Tools Therapeutics and Fujifilm Middle East FZE Partner to Extend Access to Innovative Treatments for Obesity","datePublished":"2025-06-30T08:03:47+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/"},"wordCount":658,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250630084663\/en\/2505963\/22\/ETT_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/","url":"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/","name":"Endo Tools Therapeutics and Fujifilm Middle East FZE Partner to Extend Access to Innovative Treatments for Obesity - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250630084663\/en\/2505963\/22\/ETT_logo.jpg","datePublished":"2025-06-30T08:03:47+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250630084663\/en\/2505963\/22\/ETT_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250630084663\/en\/2505963\/22\/ETT_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Endo Tools Therapeutics and Fujifilm Middle East FZE Partner to Extend Access to Innovative Treatments for Obesity"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61504"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61504\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}